melanotan-ii has been researched along with silicon in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herzig, KH; Järvinen, K; Kilpeläinen, M; Lehto, VP; Mönkäre, J; Riikonen, J; Salonen, J; Vlasova, MA | 1 |
Herzig, KH; Järvinen, K; Kilpeläinen, M; Lehto, VP; Mönkäre, J; Riikonen, J; Salonen, J; Vlasova, M | 1 |
2 other study(ies) available for melanotan-ii and silicon
Article | Year |
---|---|
Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.
Topics: alpha-MSH; Animals; Chemical Phenomena; Delayed-Action Preparations; Drinking; Drug Carriers; Heart Rate; Injections, Subcutaneous; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Microspheres; Nanotechnology; Peptides, Cyclic; Rats; Rats, Wistar; Silicon; Solubility; Surface Properties; Time Factors | 2011 |
Mesoporous silicon microparticles as carriers for peptides.
Topics: alpha-MSH; Animals; Drug Carriers; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Peptides, Cyclic; Porosity; Silicon | 2010 |